{"date":"2026-09-01","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2026-09-01-2003-1mommt4","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-09-01","time":"20:03:14","subject":"代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright&Co.投資銀行舉辦之第28屆全球投資年會(H.C. Wainwright 28thAnnual Global Investment Conference)","clause":"第44款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-09-01 20:03，「代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright&Co.投資銀行舉辦之第28屆全球投」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-09-01-2002-gdlprn","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-09-01","time":"20:02:52","subject":"代重要子公司Belite Bio, Inc公告受邀參加Morgan Stanley投資銀行舉辦之第24屆全球醫療年會(Morgan Stanley 24thAnnual Global Healthcare Conference)","clause":"第44款","fact_date":"2026-09-14","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-09-01 20:02，「代重要子公司Belite Bio, Inc公告受邀參加Morgan Stanley投資銀行舉辦之第24屆全球醫療年會(M」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-09-01-2002-flq0cw","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-09-01","time":"20:02:17","subject":"代重要子公司Belite Bio, Inc公告受邀參加Cantor Fitzgerald投資銀行舉辦之全球醫療論壇(Global Healthcare Conference)","clause":"第44款","fact_date":"2026-09-11","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-09-01 20:02，「代重要子公司Belite Bio, Inc公告受邀參加Cantor Fitzgerald投資銀行舉辦之全球醫療論壇(Gl」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-09-01-2001-17mfh1r","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-09-01","time":"20:01:50","subject":"代重要子公司Belite Bio, Inc公告受邀參加Wells Fargo投資銀行舉辦之第21屆醫療年會(Wells Fargo 21st AnnualHealthcare Conference)","clause":"第44款","fact_date":"2026-09-08","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-09-01 20:01，「代重要子公司Belite Bio, Inc公告受邀參加Wells Fargo投資銀行舉辦之第21屆醫療年會(Wells 」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-09-01-1733-100esni","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-09-01","time":"17:33:24","subject":"公告本公司研發主管異動","clause":"第11款","fact_date":"2026-09-01","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-09-01 17:33，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-09-01-1636-10k3mff","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-09-01","time":"16:36:57","subject":"代子公司長聯科技股份有限公司公告國泰人壽保險股份有限公司累積次順位公司債","clause":"第20款","fact_date":"2026-09-01","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-09-01 16:36，「代子公司長聯科技股份有限公司公告國泰人壽保險股份有限公司累積次順位公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-09-01-1605-1vhu1xi","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-09-01","time":"16:05:51","subject":"公告本公司發言人異動","clause":"第8款","fact_date":"2026-09-01","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-09-01 16:05，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-09-01-1544-lwss1b","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-09-01","time":"15:44:21","subject":"公告本公司訂定現金增資發行新股認股基準日等相關事宜","clause":"第9款","fact_date":"2026-09-01","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-09-01 15:44，「公告本公司訂定現金增資發行新股認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2026-09-01-1542-54swv6","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2026-09-01","time":"15:42:59","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-09-01","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2026-09-01 15:42，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-09-01-1434-s364tb","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-09-01","time":"14:34:34","subject":"公告本公司訂定除息基準日","clause":"第14款","fact_date":"2026-09-01","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-09-01 14:34，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-09-01-1410-vqkii","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-09-01","time":"14:10:41","subject":"公告本公司註銷限制員工權利新股減資變更登記完成","clause":"第35款","fact_date":"2026-09-01","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-09-01 14:10，「公告本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-09-01-0503-1q6wz7h","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-09-01","time":"05:03:23","subject":"公告本公司人事異動","clause":"第8款","fact_date":"2026-08-31","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-09-01 05:03，「公告本公司人事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}